Algipharma
Phase 1Biopharmaceutical company with focus on respiratory diseases (Cystic Fibrosis, COPD), infections and biofilms.
Founded
2005
Focus
Small Molecules
About
Biopharmaceutical company with focus on respiratory diseases (Cystic Fibrosis, COPD), infections and biofilms.
Funding History
4Total raised: $22.8M
Series A$15MUndisclosedJun 15, 2020
Seed$3MUndisclosedNov 15, 2019
Grant$2.8MResearch Council of NorwayJun 15, 2018
Grant$2MResearch Council of NorwayMay 15, 2017
Company Info
TypePrivate
Founded2005
LocationBergen, Norway
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
Bio-Me
Pre-clinical · Oslo
CardiNor
Pre-clinical · Oslo
Gentian USA
Pre-clinical · Moss
Hemispherian
Phase 1 · Oslo
NaDeNo
Phase 1 · Oslo
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile